2950-2128

Innovative Practice in Breast Health

Elsevier

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 29 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact29 DOIs
2

Attach ORCID iDs across 6 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact6 DOIs
3

Deposit reference lists for 5 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact5 DOIs

DOIs for this ISSN

Showing the top 5 of 29 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Breast cancer detection redefined: Integrating Xception and… (10.1016/j.ibreh.2025.100038)
Abstract
26.03 10
2 A prospective study to assess the quality of life (QOL) in b… (10.1016/j.ibreh.2024.100004)
Abstract
21.13 6
3 A review of the literature: Mammography positioning, body ha… (10.1016/j.ibreh.2025.100034)
Abstract
15.05 3
4 Breast cancer characteristics in elderly women: A comprehens… (10.1016/j.ibreh.2024.100001)
Abstract
11.93 2
5 Preventive, personalized, and precision medicine and biomark… (10.1016/j.ibreh.2025.100045)
Abstract
11.93 2
6 Is immediate breast reconstruction surgery safe for elderly… (10.1016/j.ibreh.2024.100005)
Abstract
7.53 1
7 Artificial intelligence for hierarchical tumor masking poten… (10.1016/j.ibreh.2024.100014)
Abstract
7.53 1
8 A critical analysis of the potential of formal education pro… (10.1016/j.ibreh.2024.100023)
Abstract
7.53 1
9 Exploring the potential of CRISPR in triple-negative breast… (10.1016/j.ibreh.2024.100028)
Abstract
7.53 1
10 Techniques and complications of non-genetic risk reducing ma… (10.1016/j.ibreh.2024.100002)
Abstract
0.00 0
11 Non-genetic indications for risk reducing mastectomies: Guid… (10.1016/j.ibreh.2024.100003)
Abstract
0.00 0
12 Systematic review of added immunotherapy in traditional trea… (10.1016/j.ibreh.2024.100013)
Abstract
0.00 0
13 Advancements in managing pure ductal carcinoma in situ: An 1… (10.1016/j.ibreh.2024.100022)
Abstract
0.00 0
14 History of breast reconstruction : Towards the era of endosc… (10.1016/j.ibreh.2025.100035)
Abstract
0.00 0
15 Endoscopic mastectomy: quick and fast in 5 steps (10.1016/j.ibreh.2025.100039)
Abstract
0.00 0
16 Genome medicine and breast cancer in Africa (10.1016/j.ibreh.2025.100040)
Abstract
0.00 0
17 Proposed French recommendations for breast cancer screening… (10.1016/j.ibreh.2025.100041)
Abstract
0.00 0
18 Bosutinib: Transforming the therapeutic landscape for HER2-p… (10.1016/j.ibreh.2025.100042)
Abstract
0.00 0
19 Therapeutic excision results in benign and borderline breast… (10.1016/j.ibreh.2025.100043)
Abstract
0.00 0
20 Ultrasound-guided marker clip placement and biopsy in level… (10.1016/j.ibreh.2025.100044)
Abstract
0.00 0
21 Recent advancements in machine learning and deep learning fo… (10.1016/j.ibreh.2026.100050)
Abstract
0.00 0
22 Inference-based machine learning models to classify breast c… (10.1016/j.ibreh.2026.100051)
Abstract
0.00 0
23 A TCM-based continuing nursing care plan for chemotherapy-in… (10.1016/j.ibreh.2026.100052)
Abstract ORCID
0.00 0
24 Adaptive density-informed AI framework for improving breast… (10.1016/j.ibreh.2026.100053)
Abstract
0.00 0
25 ours (10.1016/s2950-2128(24)00008-3)
Abstract References ORCID
0.00 0
26 ours (10.1016/s2950-2128(24)00017-4)
Abstract References ORCID
0.00 0
27 Ours (10.1016/s2950-2128(24)00021-6)
Abstract References ORCID
0.00 0
28 Ours (10.1016/s2950-2128(24)00031-9)
Abstract References ORCID
0.00 0
29 Editorial board (10.1016/s2950-2128(25)00013-2)
Abstract References ORCID
0.00 0